Item No.CLM-11740-CA
2-Amino-2ʹ-deoxyadenosine 5ʹ-triphosphate, NH₄⁺ (ribose-1ʹ,2ʹ,3ʹ,4ʹ,5ʹ-¹³C₅, 99%) (in solution) CP 95%

Synonyms
Formula
CAS Number LabeledN/A
CAS Number Unlabeled81503-63-1
EC Number
Item no. | Package size | Availability | List Price (USD) | Your Price (USD) | ||
---|---|---|---|---|---|---|
CLM-11740-CA | 100 µmol | CIL will contact you with availability. | $2678 | Your Price (USD) $2678 |
Properties
Molecular Weight
Chemical Purity95%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage Temp
Product Description
2-Amino-2ʹ-deoxyadenosine 5ʹ-triphosphate (2-amino-dATP)s is utilized by a variety of virus as an alternative to dATP and used in the DNA of the virus. This modification has fluorescence properties.
Application Descriptions
Related Products
Safety Information
Hazard Pictograms
Signal Word
Hazard Statement
Reviews (0)
There are no reviews yet.
Item No.CLM-11740-CA
2-Amino-2ʹ-deoxyadenosine 5ʹ-triphosphate, NH₄⁺ (ribose-1ʹ,2ʹ,3ʹ,4ʹ,5ʹ-¹³C₅, 99%) (in solution) CP 95%

Dry ice shipment required. 0.1mmol in 1mL of H₂O (100mM); pH 7.5. Avoid repeated freeze-thaw cycles.
Synonyms
Formula
CAS Number LabeledN/A
CAS Number Unlabeled81503-63-1
EC Number
Item no. | Package size | Availability | List Price (USD) | Your Price (USD) | ||
---|---|---|---|---|---|---|
CLM-11740-CA | 100 µmol | CIL will contact you with availability. | $2678 | Your Price (USD) $2678 |
Do you need bulk quantities of this material?
Pleaseto request pricing and availability for CLM-11740-CA
Properties
Molecular Weight
Chemical Purity95%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage Temp
Related Products
Product Description
2-Amino-2ʹ-deoxyadenosine 5ʹ-triphosphate (2-amino-dATP)s is utilized by a variety of virus as an alternative to dATP and used in the DNA of the virus. This modification has fluorescence properties.
Application Descriptions
Safety Information
Hazard Pictograms
Signal Word
Hazard Statement
Reviews (0)
There are no reviews yet.